FTC Ends Subscription Trap with Final Click to Cancel Rule
October 16, 2024 — Following a vote from the Federal Trade Commission to finalize its “click to cancel” rule, which forbids subscription and membership services from making it difficult for consumers to unsubscribe from services or halt recurring payments, the American Economic Liberties Project released the following statement.
FTC and DOJ’s Final HSR Form Will Modernize and Streamline Decades-Old Merger Review Process
October 10, 2024 — In response to news that the Federal Trade Commission voted unanimously to finalize the FTC and Department of Justice’s updated HSR form – a key pre-merger filing document that has not been updated since 1978 – to modernize and streamline the merger review process, the American Economic Liberties Project released the following statement.
OCC Chief Hsu Sides With Big Banks and Lobbyists Over Small Business, Consumers by Seeking to Block Illinois Interchange Fees Law
October 8, 2024 — Following news that Office of the Comptroller of the Currency (OCC) issued an amicus brief asking the a court to invalidate “The Illinois Interchange Fee Prohibition Act,” which seeks to ban credit and debit card issuers from charging interchange fees on taxes and tips, the Lower Credit Card Fees Coalition today released the following statement.
Economic Liberties Applauds Proposed Philadelphia Law to Ban Algorithmic Rent-Fixing
September 27, 2024—In response to news that Philadelphia Councilmember Nicolas O’Rourke has introduced a bill to ban algorithmic price setting in the rental housing market, the American Economic Liberties Project released the following statement.
Economic Liberties and Partners Call on FTC to Block McKesson and Cardinal Health Acquisitions
September 26, 2024 — The American Economic Liberties Project, along with five other advocacy organizations, sent a letter to the Federal Trade Commission (FTC) today urging the agency to block two major acquisitions proposed by McKesson Corporation and Cardinal Health, which are both seeking to acquire management service organizations (MSOs) that oversee oncology practice networks. As Americans continue to struggle with high drug prices, the letter argues these deals would further entrench the dominance of these pharmaceutical distribution giants, exacerbate drug shortages, and raise costs for cancer patients.